Juelich, Germany

Dieter Willbold

USPTO Granted Patents = 20 

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Mind of Dieter Willbold

Introduction

Dieter Willbold is a distinguished inventor based in Juelich, Germany, renowned for his significant contributions to the field of biomedicine. With an impressive portfolio of 20 patents, his work primarily focuses on innovative therapeutic strategies for neurological conditions, including Alzheimer's disease.

Latest Patents

Among Dieter Willbold's latest innovations are two notable patents. The first patent addresses amyloid-beta-binding peptides aimed at the treatment and diagnosis of Alzheimer's disease. This invention revolves around the development of specific peptides that can bind to amyloid-beta, providing a potential pathway for not only understanding the disease but also for devising effective treatments.

The second recent patent describes methods for treating chronic and neuropathic pain mediated by N-type neuronal calcium channels using D-enantiomeric peptides. This invention presents a composition that includes peptides from the RD2 and D3 groups, which have demonstrated potential as analgesics in pain therapy. The innovative use of these peptides represents a promising approach to alleviating chronic and neuropathic pain by inhibiting specific neuronal calcium channels.

Career Highlights

Throughout his career, Dieter Willbold has been associated with prominent institutions such as Forschungszentrum Jülich GmbH and Heinrich Heine University. His research at these organizations has contributed significantly to advancements in biomedical technologies, particularly in the realm of neuroscience and pain management.

Collaborations

Dieter's work has often involved collaboration with notable colleagues, including Susanne Aileen Funke and Luitgard Nagel-Steger. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact and reach of his innovative work.

Conclusion

Dieter Willbold stands out as a significant figure in the world of innovation, particularly in the areas of neuropathic pain and Alzheimer’s disease. His ongoing contributions and patent developments not only showcase his inventive spirit but also promise advancements in therapeutic options for conditions that affect millions globally. As he continues his research and development, the scientific community eagerly anticipates the results of his innovative endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…